T. Rowe Price Associates’s Orchestra BioMed OBIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-364,645	Closed	-$1.51M	–	3179
2025 Q4	$1.51M	Sell	364,645 -56,967	-14%	-$230K	﹤0.01%	1891
2025 Q3	$1.05M	Sell	421,612 -16,757	-4%	-$46.2K	﹤0.01%	2048
2025 Q2	$1.18M	Sell	438,369 -21,751	-5%	-$63.5K	﹤0.01%	1913
2025 Q1	$1.97M	Sell	460,120 -27,050	-6%	-$134K	﹤0.01%	1612
2024 Q4	$1.95M	Sell	487,170 -25,493	-5%	-$137K	﹤0.01%	1661
2024 Q3	$2.64M	Sell	512,663 -40,040	-7%	-$262K	﹤0.01%	1517
2024 Q2	$4.51M	Sell	552,703 -18,372	-3%	-$106K	﹤0.01%	1249
2024 Q1	$3.01M	Sell	571,075 -51,533	-8%	-$349K	﹤0.01%	1379
2023 Q4	$5.68M	Sell	622,608 -2,012	-0.3%	-$13.7K	﹤0.01%	1180
2023 Q3	$5.45M	Sell	624,620 -22,837	-4%	-$154K	﹤0.01%	1161
2023 Q2	$4.53M	Sell	647,457 -33,090	-5%	-$502K	﹤0.01%	1213
2023 Q1	$13.3M	Sell	680,547 -5,254	-0.8%	-$60.8K	﹤0.01%	1007
2022 Q4	$6.85M	Sell	685,801 -38,764	-5%	-$386K	﹤0.01%	1120
2022 Q3	$7.18M	Sell	724,565 -2,637	-0.4%	-$26.1K	﹤0.01%	1128
2022 Q2	$7.24M	Sell	727,202 -66,876	-8%	-$665K	﹤0.01%	1371
2022 Q1	$7.87M	Sell	794,078 -4,605	-0.6%	-$45.5K	﹤0.01%	1402
2021 Q4	$7.99M	Sell	798,683 -9,082	-1%	-$89.5K	﹤0.01%	1439
2021 Q3	$7.99M	Sell	807,765 -2,373	-0.3%	-$23.4K	﹤0.01%	1451
2021 Q2	$8.26M	Sell	810,138 -39,862	-5%	-$412K	﹤0.01%	1439
2021 Q1	$9.55M	Hold	850,000	–	–	﹤0.01%	1403
2020 Q4	$10.9M	Hold	850,000	–	–	﹤0.01%	1339
2020 Q3	$9.35M	Buy	+850,000	New	+$9.54M	﹤0.01%	1315